Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
Sinocelltech is a biopharmaceutical company founded in 2002 that develops biologic drugs, with five products approved in China and nine additional candidates in clinical development. It is publicly listed in China (stock code 688520).
1 investor
Kubota Holdings is an ophthalmic healthcare solutions company focused on developing pharmaceuticals and medical devices to help maintain and restore vision for people with eye diseases. The group engages in the research and development of treatments and medical technologies for ocular conditions.
1 investor
Uni-medica develops automated fluorescence staining and analysis systems, nucleic acid detection kits, and high-throughput sequencing products for molecular diagnostic applications including cervical cancer screening, pathogen detection, and genetic disease identification. The company serves hospitals and medical laboratories in China.
1 investor
Megarobo (ιδΌ½η§ζ) develops autonomous agents and multi-agent systems combining AI and robotic automation for smart laboratories and intelligent manufacturing. It serves clients in life sciences, chemicals, food and beverage, agriculture, consumer-grade integrated circuits, and new energy, primarily in China.
1 investor
0 investors
0 investors
0 investors
1nHealth provides digital patient recruitment for clinical research, combining digital recruitment expertise with clinical research and software engineering. It partners with organizations running clinical trials to help meet enrollment goals.
0 investors
0 investors
XXII Century develops reduced-nicotine and natural tobacco products, including low-nicotine cigarettes and additive-free tobacco blends aimed at adult smokers seeking harm reduction. The company also provides proprietary tobacco technologies to support public health research.
0 investors
0 investors
0 investors
0 investors
3Daughters develops a frameless, non-hormonal intrauterine contraceptive device (IUD) designed to reduce insertion pain and improve the user experience for women. The company is preparing clinical trials for its magnetic IUD platform and exploring applications in targeted uterine drug delivery.
0 investors
4C Medical develops minimally invasive medical devices for structural heart disease, including mitral and tricuspid valve treatments. The company serves interventional cardiologists and patients requiring catheter-based cardiac interventions.
0 investors
4D Path develops a cancer diagnostics technology that combines statistical physics with cancer biology to quantify cell cycle deregulations and tumor dynamics, generating indices that predict individual patient response to therapy. It works with cancer researchers and biopharma companies to guide personalized treatment selection and support drug discovery and development.
0 investors
0 investors
0 investors
507 Capital is a real estate investment firm that acquires and manages value-add retail shopping centers in the Midwest, generating returns through leasing vacant spaces and optimizing property operations. The firm targets triple-net lease retail properties and aims to deliver annual distributions of 6-10% with annualized returns of 16-20% upon exit.
0 investors
0 investors
60 Degrees Pharmaceuticals develops treatments and preventive medicines for vector-borne diseases such as babesiosis and malaria. Founded in 2010, the company focuses on tick-borne and parasitic infections affecting patients and travelers globally.
0 investors
0 investors
0 investors
7 Hills Pharma is a clinical-stage drug development company developing first-in-class integrin-targeted agonists intended to improve the effectiveness of cancer immunotherapies and stem cell transplantation. Its lead molecules, Alintegimod and 7HP935, target solid tumors, hematological malignancies, and CD34+ cell-based therapies.
0 investors